Is Cardiomyopathy hereditary?

Cardiomyopathy is a heterogeneous group of heart muscle diseases that can be hereditary, genetic, or acquired through non-genetic factors. While many forms of cardiomyopathy are caused by inherited mutations in genes responsible for heart muscle structure, others arise from environmental triggers, infections, or systemic conditions, meaning hereditary risk varies significantly based on the specific type and cause.

Is cardiomyopathy hereditary or genetic?

In clinical genetics, we distinguish between a condition being "genetic" (caused by an alteration in DNA) and "hereditary" (passed from parents to children). Many forms of cardiomyopathy, such as Hypertrophic Cardiomyopathy (HCM) or Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC), are primarily genetic. If a specific pathogenic variant is identified in the family, the condition is considered hereditary. However, cardiomyopathy can also be acquired—for instance, through viral myocarditis, long-term alcohol use, or chemotherapy—in which case it is not hereditary.

What are the inheritance patterns of cardiomyopathy?

The inheritance of hereditary cardiomyopathy depends on the specific gene involved. Most inherited forms follow an autosomal dominant pattern, meaning a child of an affected parent has a 50% chance of inheriting the pathogenic variant. Other patterns include:

• Autosomal Dominant: The most common pattern for familial cardiomyopathy; only one copy of the altered gene is needed to increase risk.


• Autosomal Recessive: Rare forms where both parents must carry a mutation for the child to be affected (25% risk per pregnancy).


• X-linked: Mutations on the X chromosome, often affecting males more severely.


• Mitochondrial: Inherited exclusively through the mother’s egg cells.

Is genetic testing recommended for families?

Genetic testing is a cornerstone of modern care for those with cardiomyopathy. It is generally recommended when a clinical diagnosis is made to help identify the underlying cause and determine if other family members are at risk. Testing involves analyzing a panel of genes associated with various heart conditions. If a specific mutation is found in a patient, "cascade screening" is performed, where at-risk relatives are tested for that specific variant. It is important to note that de novo mutations—spontaneous changes not inherited from parents—do occur in cardiomyopathy, though they are less common than inherited variants.

What is the role of genetic counseling?

Genetic counseling is vital for families navigating a cardiomyopathy diagnosis. A counselor helps interpret test results, explains the risk to biological relatives, and discusses reproductive options. For those planning a family, options such as Preimplantation Genetic Testing (PGT) during IVF can be explored to prevent passing a known mutation to offspring. With 256 members on DiseaseMaps.org sharing their experiences, we see that understanding the genetic basis of cardiomyopathy empowers families to make informed decisions about surveillance and long-term heart health.

Next steps

• Consult with a cardiologist specializing in inherited heart diseases or a cardiovascular geneticist.


• Request a referral for genetic counseling to create a pedigree and assess family risk.


• Gather detailed family health history, including sudden unexplained deaths or early-onset heart issues in relatives.


• Join the DiseaseMaps.org community to connect with others navigating similar genetic journeys.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Cardiomyopathy resources.


• Orphanet: Rare disease database for cardiomyopathies.


• OMIM (Online Mendelian Inheritance in Man): Catalog of human genes and genetic disorders.


• American Heart Association (AHA): Guidelines for the management of inherited cardiomyopathies.